TABLE 2

Study specimen information and molecular results of RNA analysis dataa

Patient
no.
DiagnosisSpecimen
ID
Specimen
type
No. of days of
limb weakness
to specimen
collection
EV-D68
Taqman CT
EV-D68
amplicon
read count
1AFM48135CSF2Neg0
48136NP swab432.18
2AFM48138CSF1Neg0
48137NP swab129.816
3AFM48143CSF1Neg0
48145NP swab726.2242
4AFM48127CSF6Neg0
5AFMb48130CSF19Neg0
6Unknown48124CSF5Neg0
7ADEM48134CSF7Neg0
48132NP swab8Neg0
8NMO48125CSF5Neg0
9GBS48131CSF32Neg0
10MS/ADEM48140CSF9Neg0
48139NP swab831.036
11Unknown48148CSF15Neg0
48147NP swab14Neg0
  • a The number of days from initial respiratory or gastrointestinal illness to specimen collection is the sum of the number of days of illness to limb weakness onset (Table 1) and the number of days of limb weakness to specimen collection. AFM, acute flaccid myelitis; ADEM, acute disseminated encephalomyelitis; NMO, neuromyelitis optica; GBS, Guillain-Barré syndrome; MS, multiple sclerosis; CT, threshold cycle; Neg, negative.

  • b Probable.